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Abstract
Background: Primary care physicians account for the majority of antibiotic prescribing in ambulatory care in
Germany. Respiratory diseases are, regardless of effectiveness, often treated with antibiotics. Research has found this
use without indication to be caused largely by communication problems (e.g. expectations on the patient’s part or
false assumptions about them by the physician). The present randomised controlled trial (RCT) study evaluates
whether communication training for primary care physicians can reduce the antibiotic prescribing rate for
respiratory tract infections.
Methods/Design: The study consists of three groups: group A will receive communication training; group B will be
given the same, plus additional, access to an evidence-based point-of-care tool; and group C will function as the
control group. The primary endpoint is the difference between intervention and control groups regarding the
antibiotic prescribing rate before and after the intervention assessed through routine data. The communication
skills are captured with the help of the communication instrument MAAS-Global-D, as well as individual videos of
physician-patient consultations recorded by the primary care physicians. These skills will also be regarded with
respect to the antibiotic prescribing rate.
A process evaluation using qualitative as well as quantitative methods should provide information about barriers
and enablers to implementing the communication training.
Discussion: The trial contributes to an insight into the effectiveness of the different components to reduce
antibiotic prescribing, which will also be supported by an extensive evaluation. Communication training could be
an effective method of reducing antibiotic prescribing in primary care.
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Keywords: MAAS-Global-D, Communication skills, Physician-patient relationship, Antibiotic prescribing, Primary
health care, Evidence-based medicine, Guidelines, Communicative competencies, Routine data, Respiratory
tract infections
* Correspondence: friederike.hammersen@uksh.de
1Institute of Family Medicine, University Hospital of Luebeck (UKSH), Campus
Luebeck, Ratzeburger Allee 160, 23562 Luebeck, Germany
Full list of author information is available at the end of the article
© 2016 Hammersen et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hammersen et al. Trials  (2016) 17:180 
DOI 10.1186/s13063-016-1293-5
Background
Primary care physicians account for 67 % of antibiotic
prescribing in ambulatory care in Germany [1]. In their
family practices, respiratory diseases rank among the
most frequent reasons for consulting [2]. In many of
these cases antibiotic prescribing is not indicated and
guidelines for bronchitis, sinusitis and pharyngitis recom-
mend abstaining from antibiotic treatment for the vast
majority of cases [3–7]. Rates of approximately 31 % anti-
biotic prescribing for respiratory diseases and approxi-
mately 60 % for pharyngitis/tonsillitis, however, leave
room for substantial improvement [8]. Unnecessary use of
antibiotics causes not only adverse drug reactions, but also
contributes to antibiotic resistance and unnecessary health
expenditure [9, 10]. It also reinforces patients’ incorrect
assumptions regarding the effectiveness of antibiotics for
respiratory diseases, which in turn influences their expec-
tations when suffering from similar symptoms later on
and triggers their belief in the need for antibiotics [11, 12].
Studies have found that inappropriate prescriptions of an-
tibiotics cannot be attributed solely to a lack of knowledge
in primary care physicians (PCPs). Equally important are
falsely assumed patient expectations with regard to receiv-
ing medication [11, 13] in addition to PCPs feeling pres-
sured by patients who ask for such medication [14] and
wishing to maintain good relationships with patients or to
avoid confrontations and the need to explain the differ-
ences between viruses and bacteria [11]. Physicians state
that explaining takes up time and that explanations are
often not understood by the patient, whereas prescribing
antibiotics is a quicker and simpler course of action [11].
Studies have revealed the possibility of decreasing anti-
biotic prescribing in primary care by enhancing PCPs’
communication skills [15–17]. Communication training
proved to be an effective intervention, sometimes paired
with further elements, such as point-of-care testing,
delayed prescribing or additional patient education
material [12, 16–19]. The achieved effects were an
absolute reduction of 10–12 % in the rate of anti-
biotic prescribing [15–17], corresponding to a relative
reduction of 25-40 % [16, 18]. This reduction of antibiotic
prescribing does not, or only to a very modest extent, im-
pact negatively on patient satisfaction [12, 16, 17, 19]. Fur-
thermore, a review on interventions to improve antibiotic
prescribing concluded that multiple interventions, which
contain more than one interventional module, are more
likely to be effective than single intervention strategies
[15]. Of the tested combinations of modules, educational
meetings with educational material for the physician
scored best [15]. Additionally, active clinician education
strategies (e.g. interactive workshops) appear to be super-
ior to passive ones (e.g. educational material only) [16].
Adequate communication skills are probably more
important in primary care than in any other medical
specialty. However, the German specialist medical train-
ing for PCPs lacks nationwide, structured training on
communication skills [20]. This is in contrast to the
situation in the Netherlands, for example, where an
instrument to measure physicians’ communication and
medical skills is incorporated in a structured curriculum
on communication skills. The physicians record videos
of physician-patient consultations which are then rated
using the instrument produced to examine these skills.
The instrument is now widely used in medical schools
as well as in specialist training [21]. This instrument,
named MAAS-Global-D, was recently translated and
adapted for use in Germany [22]. Against this back-
ground, our study aims to investigate whether the rate
of antibiotic prescribing can be reduced with the help of
MAAS-Global-D-based communication training. We
postulated the following research hypothesis:
In the intervention groups, the rate of antibiotic
prescribing by PCPs for acute bronchitis, sinusitis and
pharyngitis decreases following the communication train-
ing compared to the control group with no intervention.
Based on the MAAS-Global-D, we designed a multiple-
component intervention, which, in brief, includes:
 Communication training for PCPs with interactive
elements: the programme will be suitable for PCPs
with professional experience. After the training
sessions, the PCPs submit videos displaying their
own communication with patients and receive
feedback on it.
 Further information material for PCPs: they will
be educated in the usage of Evidence-based
Medicine – Guidelines (EbMG), a point-of-care
tool, which will be made available online to one
of the intervention groups during the whole
study period and which aims to support and
facilitate decision-making [23].
The groups compared will be:
Group A: Intervention group A with communication
training
Group B: Intervention group B, same training as group
A plus access to EbMG
Group C: Control group C with no intervention
By assessing and evaluating the communication train-
ing, it can be adapted and possibly also improved. Since
the MAAS-Global-D instrument, as well as the associ-
ated manual, are published for free download, they will
be available in order to establish nationwide training to
decrease antibiotic prescribing in primary care and
could be implemented in specialty training for PCPs
later on.
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Objectives
Primary objective
To assess whether communication training for PCPs
working in family practices in the federal state of
Schleswig-Holstein (SH) in northern Germany leads to a
reduction of antibiotic prescribing rates for acute bron-
chitis, sinusitis and pharyngitis compared to a control
group (A + B versus C).
Secondary objectives
1. To assess whether provision and training in the
usage of EbMG leads to an additional reduction of
antibiotic prescribing (A versus B)
2. To assess whether PCPs who score higher on the
MAAS-Global-D instrument (meaning they have
better communication skills) as measured through
videos of their consultations prescribe antibiotics less
often than PCPs with a lower score
3. To evaluate the communication training as well as
the use and the usefulness of EbMG by interviewing
the PCPs in a process evaluation
Methods/Design
Trial design
The trial is designed as a randomised, controlled trial
postulating superiority of the interventions over conven-
tional care in family practices. The study consists of
three arms and a primary endpoint of antibiotic pre-
scribing rates of PCPs for acute bronchitis, sinusitis and
pharyngitis over a 3-month period starting around
1 month after the communication training and educa-
tion in the usage of EbMG. Randomisation of either of
the two intervention groups or the control group will be
performed at practice level with a 1:1:1 allocation.
Therefore, random permuted blocks will be generated.
Due to the data format, practices with more than one
physician represent one case. The person assigning the
participants to the groups will do so blinded. Further
blinding does not fit the trial design.
Study setting
The trial will be conducted in the population of PCPs in
SH. In total, there are about 1900 PCPs in SH who are
working in family practices, including rural as well as
urban sites. In Germany, all resident PCPs belong to a
subdivision of the Association of Statutory Health Insur-
ance Physicians (KV). These subdivisions are responsible
for the remuneration of physicians’ services when treat-
ing patients who are covered by statutory health insur-
ance – approximately 87 % of all inhabitants [24]. Since
2011, all practices belonging to KV are obligated to do
their accounting online, which requires a connection to
the data centre of their KV. These routine data of the
KV of Schleswig-Holstein (KVSH) will be the data basis
for the present study concerning data about diagnoses.
Information about prescriptions are obtained through a
more complex process including pharmacies and the
Central Research Institute of Ambulatory Health Care in
Germany (ZI), but will also be provided by a federal
subdivision of the KV together with data about diagno-
ses. Therefore, all data is referred to as ‘routine data’ in
this article. For our objectives it is necessary to establish
a connection between the PCPs and their data on
diagnoses and antibiotic prescriptions. Each practice
possesses an identification number, which can be used
for this purpose. The study centre is located at the Insti-
tute of Family Medicine at the University Hospital of
Luebeck (UKSH), SH. It will work in close collaboration
with a KVSH data manager for the purpose of data
analysis. Prior to analysis, official approval from the
‘Independent Regional Centre for Data Protection’
(Unabhaengiges Landeszentrum fuer Datenschutz) of
the federal state of SH is sought.
Interventions
The study incorporates a multiple-component interven-
tion corresponding to the two interventional study arms
(group A and B). Both intervention groups receive com-
munication training with an interactive workshop char-
acter (4.5 hours of input), which is held at the Institute
of Family Medicine. It is designed as a face-to-face deliv-
ery by members of the research team, including an ex-
pert on physician-patient communication.
Firstly, the speakers establish the relevance and success
of physician-patient communication. The speakers then
provide input concerning the associated evidence base.
Furthermore, the participants learn the different com-
municative phases of a consultation, corresponding
communication skills as well as general communica-
tion skills for the whole consultation (e.g. adequate
provision of information, structuring and empathy,
shared decision-making). These topics also function as
an introduction to the MAAS-Global-D rating scale.
The PCPs have the opportunity to evaluate a video
with the recent learned criteria of the MAAS-Global-
D, as well as to perform a consultation with a patient-
actor themselves. The curriculum is derived from the
aforementioned structured Dutch communication train-
ing, the MAAS-Global-D instrument, as well as from
further evidence about successful physician-patient
communication.
Group B receives an additional 1.5 hours of face-to-face
input comprising education in the use of EbMG online.
With online-access to this point-of-care tool, further
information material on the prescribing of antibiotics for
uncomplicated respiratory infections is provided for group
B. The German version of the EbMG, which was originally
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developed in Finland, incorporates a regularly updated
point-of-care tool with guidelines based on current best
evidence, including videos, audio samples, pictures, links
to evidence summaries and articles from the Cochrane
library in addition to ready-to-print patient information
[23]. It has received National Institute for Health Clinical
Excellence (NICE) accreditation [25].
Another part of the intervention for both groups targets
organisational matters: video recording in the PCPs’ prac-
tices, how to install the webcam and the informed consent
forms for all patients. Each PCP receives a secure USB
stick with a password that is used to transfer the videos to
the study centre. To increase adherence, a monthly email
will be sent to the participants reminding them of the
videos and the book vouchers for each video.
The control group does not receive any intervention
and provides ‘usual’ care to patients.
Eligibility criteria
Written informed consent will thus be obtained from all
participants: PCPs, their colleagues as well as patients to
be filmed.
PCPs
A PCP is defined as either a general practitioner or an
internist working in primary care. Inclusion criteria are:
 PCPs who have been active members of KVSH for a
minimum of 5 years
 provide written, informed consent
 work as a PCP in a practice, and
 in case they work with several PCPs in a group
practice, all of them must give written, informed
consent, since it is expected that a PCP in this
working environment who receives the
communication training will influence his colleagues
The exclusion criterion is:
 withdrawal of informed consent
Patients
The patients involved in the video recording are recruited
by the PCPs themselves in their own practices. Inclusion
criteria are:
 written, informed consent before recording
 minimum age of 18 years
 a first consultation about acute symptoms (though
not necessarily about respiratory infections)1
The exclusion criterion is:
 insufficient knowledge of the German language
Outcomes
Primary outcome measures
 Evaluation of the antibiotic prescribing rate in both
intervention groups compared to the control group
between baseline (meaning the prescribing rate of
the three periods April–June 2013, 2014, and 2015)
and post-intervention (April–June 2016)
To determine the antibiotic prescribing rate for each
PCP, all patients with the target-diagnoses of acute bron-
chitis, sinusitis and pharyngitis (classified by the Inter-
national Classification of Diseases, version 10 (ICD-10)
codes: J01.-; J02.-; J20.- [26]) are identified in the routine
data of KVSH and the proportion of these patients who
receive antibiotic prescriptions is calculated. The three
diagnoses and corresponding antibiotic prescriptions are
condensed into one rate for each PCP (in %). This will
be completed for two time periods (t0 = baseline, before
intervention: mean of quarter II in the years 2013–2015;
t1 = post-intervention: quarter II in the year 2016). For
each PCP the change from t0 to t1 will be calculated
(rate t1-rate t0). For each study group, the mean of the
antibiotic prescribing rates of all PCPs in the group
(at t0 and t1) will be calculated. For our primary end-
point the two intervention groups will be regarded as
one group which is compared to group C.
Inclusion and exclusion criteria for data
To obtain the proportion of cases with the defined
diagnoses and antibiotic prescribing for each PCP, the
routine data are filtered for the following: inclusion of all
cases with at least one visit to a PCP during time period
t0 or t1, respectively, who were 18 years or older, had a
diagnosis of acute bronchitis, sinusitis or pharyngitis.
Exclusion if diagnosis of a further (bacterial) infection in
the same quarter (ICD-10 codes A00.- till A37.-, A39.- till
A79.-, J15.-, J17.- and J18.-). These cases need to be
excluded because data about diagnoses are only available
for each quarter and not on a daily basis. Furthermore,
KVSH data about prescriptions cannot be linked directly
to these diagnoses. If a patient is prescribed an antibiotic,
it could either be for one of the defined diagnoses or
another bacterial infection in the same quarter of the year.
Hence all patients with the latter diagnoses are excluded.
Furthermore, cases are excluded if multiple diagnoses of
the defined diseases are made or the same diagnosis is
made multiple times. Additionally, cases are excluded if
they are diagnosed with a specific chronic disease (ICD-10
codes I50.-, J44.-, J45.-, C00-C75) or have a diagnosis
related to pregnancy or childbirth (ICD-10 codes O). The
presence of these diagnoses or the same diagnosis mul-
tiple times might qualify them as cases at higher risk or
indicate a recurring disease where antibiotic prescribing is
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indicated. Eligible antibiotics are systemic antibiotics (40
different ATC codes, identified in [2]).
Using routine data is a fairly objective method in
analysing prescribing behaviour compared to subjective
methods such as interviewing patients retrospectively
about their diagnosis and the antibiotics they received.
Although this corresponds with high reliability, the
validity might be compromised. ICD-10 codes and rou-
tine data might not represent the actual diagnoses and
reasons for the consultation, but instead need to be
completed for administrative reasons. Nevertheless,
these limitations of routine data affect both intervention
and control groups equally and, therefore, should not
interfere with our results. Moreover, routine data is col-
lected anyway and thus physicians are not burdened with
additional documentation when participating in the study.
Secondary outcomes measures
 Evaluation of antibiotic prescribing rate in
intervention group A versus intervention group B
between t0 and t1
The antibiotic prescribing rates calculated for the
primary outcome will also be used for the analysis of the
secondary outcomes, i.e. the mean of change in the
antibiotic prescribing rate from t0 to t1. Study groups A
and B will be compared to assess whether there is an
additional effect in study group B due to using EbMG.
 Evaluation of antibiotic prescribing rates depending
on PCPs’ communication skills
PCPs’ communication skills will be defined over their
MAAS-Global-D score, which is computed by rating the
PCPs’ videos with the MAAS-Global-D instrument. For
this only the PCPs of the intervention groups are consid-
ered. For each PCP a mean score is calculated based on
the six videos recorded during t1.
To evaluate the association between the MAAS-
Global-D score and the antibiotic prescribing rate dur-
ing t1, a linear regression will be calculated with each
PCP’s antibiotic prescribing rate at t1 as dependent
variable. Independent variables to be included in the
model are the MAAS-Global-D score, the antibiotic
prescribing rate at t0 and the difference between the
two rates, the PCP’s field of specialisation, their kind
of practice (single versus shared) and its location
(urban versus rural) as well as the number of patients
per quarter.
 To evaluate the communication training as well as
the use and the usefulness of the EbMG by
interviewing the PCPs
This process evaluation will be undertaken after t1 in
terms of a qualitative, guided interview. As it is unlikely
that all PCPs shall be willing to participate in the quali-
tative interview, additionally every participant is asked to
fill in a semi-structured questionnaire with open and
closed questions. The topics of both interviews will
concern whether and in what way the communication
training was helpful, which elements of it the PCPs used,
further enablers and barriers to implementing our com-
munication recommendations as well as additional
feedback about the communication training.
A participant timeline along with the outcomes is
provided in detail in the flow diagram in Fig. 1.
Sample size
Primary outcome: evaluation of antibiotic prescribing rate
in intervention groups compared to control group
Previous research has established that communication
training can lead to a reduction of 12 % (95 % confi-
dence interval −18.9 to −4.0) in antibiotic prescribing
[17], with a mean of −4 % (standard deviation (SD) 15.6)
in the intervention group and +8 % (SD 19.2) in the
control group, respectively, from t0 to t1.
Additional definitions for sample size calculations are
a power of 80 % and α = 5 %. A t test for unequal group
sizes (Satterthwaite’s t test) results in 28 PCPs per study
arm. Including an estimated dropout of 10 %, the total is
93 participants, yielding 31 per study arm.
Recruitment of participants
All PCPs who have been members of the KVSH for
at least the last five preceding years and who have
made diagnoses of the defined ones are contacted via
mail (n = 977). Furthermore, the information about
the study and the invitation are spread through differ-
ent channels: the Hausaerzteverband SH, which is a
federal division of the biggest association of PCPs in
Germany, further regional associations (Aerztenetze)
as well as in the group of medical student trainers at
the University of Luebeck.
Besides information on the study and the informed
consent form, the invitation letter highlights the incentives
for participants: credit points for continuing medical
education as well as book vouchers. If more eligible PCPs
apply for participation than needed, the first 93 are
included and a waiting list is created.
Data collection and management
Diagnoses and antibiotic prescribing
KVSH provides data about diagnoses to ZI over an
intermediate body. ZI also has data on redeemed anti-
biotic prescriptions. Diagnoses and prescriptions are not
originally linked but data sources are joined by ZI and
provided as a joined data stream to KVSH. This routine
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data by KVSH forms the basis of a shortened dataset for
the study team. Individual patients cannot be identified
in the data set due to anonymisation.
Communication skills
During t1, PCPs in the intervention groups record six
videos of consultations in their practice. The PCPs
choose the videos themselves (preferably ones in which
the PCP recognises their own usual behaviour) and send
them via a secure USB stick to the study centre. The
videos are then rated by researchers using the MAAS-
Global-D rating scale. The English version of the instru-
ment has been tested for reliability with Cronbach’s α
and showed values of 0.78 - 0.86 [27, 28]. Furthermore,
a comparison of the rating scale and the Common
Ground instrument showed an acceptable value
(0.59), which is an indicator for convergent validity
[28].
Data quality
A short questionnaire about the PCPs’ socio-demographics,
the results of the MAAS-Global-D rating and the data from
the process evaluation will be entered locally at the study
centre. Where applicable, values can be chosen from a list
of codes and their meaning is captured in a codebook. To
secure and promote data quality, all data will be checked
Potential participants return 
informed consent 
Excluded: give no 
informed consent; 
return of non-
response sheet  
Rating of videos with the MAAS-
Global-D and preparation of feedback 
for the PCPs
Participants record 6 videos in their 
practices 
April - June 2016 (13 weeks = t1)
Allocated to intervention group A or B: 
receive communication training 2 
afternoons (4.5h in total); Group B 
additionally receives introduction to 
EbMG (1.5h) 
February/March 2016 
Analysis of antibiotic prescribing rate in defined diagnoses at baseline (=t0) 
April – May 2016 




Randomization & send out date of training to participants 
January 2016
Enrollment
Invitation to participate sent via mail, e-mail and 







Analysis of antibiotic prescribing rate in defined diagnoses at t1
Feb - March 2017 
Loss to follow-up, discontinued or withdrawal of informed consent (n=?) 
Evaluation:  
1) qualitative, guided interview 
2) standardized questionnaire 
feedback letter
Fig. 1 Flow diagram participant timeline. SH = Schleswig-Holstein, federal state in northern Germany; PCPs = primary care physicians; h = hours;
EbMG = Evidence-based Medicine – Guidelines; t0 = baseline, pre-intervention time period; t1 = post-intervention time period; n = number of cases
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for double data entry and plausibility of range of
values before analysis. Potential changes to the dataset
are documented in a separate file.
Analysis
Statistical methods concerning study outcomes
Primary outcome All randomised PCPs will be in-
cluded and analysed as randomised. The combined
intervention groups’ rate (group A + B) will be com-
pared to the control group (C) with a t test for the
group mean (= proportion of antibiotic prescribing).
As an effect size the difference of differences or differ-
ence of change [16], respectively, is chosen. This
depicts the difference from t0 to t1 between the inter-
vention and control groups.
Secondary outcomes The additional effect of the EbMG
will be evaluated similarly to the primary outcome under
consideration of group A versus group B. Since the
sample size is calculated with regard to the primary
outcome, these analyses are only exploratory.
For further secondary outcomes, PCPs who adhered to
the protocol will be encompassed in the analyses. Ad-
herence refers to the intervention groups and whether
each PCP has submitted a minimum of at least four
videos. To explore differences in the antibiotic pre-
scribing rate at t1 depending on the communication
skills of the PCPs in group A and B, linear regression
analyses will be conducted.
Quantitative data from the evaluation questionnaire
will be presented descriptively only.
For all analyses, 95 % confidence intervals will be
calculated where applicable.
Additional analyses
Depending on the scale level and the distribution, para-
metric or non-parametric methods (e.g. Chi-squared
test, t test or Mann-Whitney U test) will be applied to
ascertain whether differences exist between intervention
groups (A + B) and the control group at baseline.
Ethics
PCPs and their filmed patients will participate voluntar-
ily and may withdraw from participation at any time
without giving reasons. No data monitoring committee
is necessary because of the known minimal to negligible
risks of the intervention. No adverse events are to be
expected in this kind of study. However, participants
(PCPs) and the filmed patients can contact the study
team with further enquiries.
Due to the fact that prescribing data is pseudonymised
by an external position of trust at ZI and the diagnoses are
transferred in compliance with the legal requirements of
the national data protectionist, no data can be reduced to
a specific person.
Moreover, values which will be interpreted in the
analyses are an aggregate function of pseudonymised
prescription data in terms of the patient. The reference
to the individual patient is no longer possible and this is
in line with this part of data protection. The second and
sufficient part of data protection, which refers to the
misuse of routinely collected data in the research
project, will be ensured with the help of a statutory
application at the Independent Centre for Data Protec-
tion SH (ULD), which is in frame for such cases.
The study was approved by the ethics committee of
Luebeck University before the recruitment of partici-
pants on 9 June 2015 (number of approval: 15-139).
Discussion
The MAAS-Global-D instrument, which measures com-
municative and medical skills, has recently been translated
into German [22] and will be tested in a randomised
controlled trial in primary care in Germany for the first
time. The trial design (three arms: multiple interventional
elements and comparison with a control group) contrib-
utes to an insight into the effectiveness of the different
components to reduce antibiotic prescribing, which will
also be supported by extensive evaluation. Thereby, bar-
riers and enablers to implement parts of or the whole of
the communication training on a large scale will be
worked out. The choice of active clinician education
procedures and further educational material for the PCP,
such as EbMG, would appear to be promising intervention
strategies [15, 16].
Strengths and limitations of the study
The randomisation will ensure a random distribution of
characteristics and probably create nearly equal groups.
Due to the number of participants, a prior stratification
would not be reasonable. A limitation of the study is
that randomisation must be carried out at practice
level because the routine data cannot be assigned to
the individual PCP in group practices. Therefore, untrained
PCPs in group practices might bias the effect of the
intervention.
Using the PCPs’ routine data instead of self-
documentation bears the advantage that the data is not
subject to selection bias: for example, if a PCP does not
include all cases with the defined diagnoses in their
documentation or if patients deny being in the study.
Also, recall bias or effects due to the interviewer can be
excluded. The Hawthorne effect is probably smaller, too,
as the PCPs’ attention is not constantly drawn to
patients with the relevant diagnoses. The routine data
further allows the possibility of including several years as
t0, which can balance extremes due to different seasonal
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variations. Extremes in t1 cannot be balanced, but a rise in
antibiotic prescriptions due to a growth in infections in
this time period would equally affect intervention and
control groups.
Routine data is, at the same time, secondary data with
known limitations: an often poorer data quality caused,
for example, by misclassifications goes along with no
possibility of external validation (e.g. of diagnoses) in our
subsample. Further weaknesses are the lack of information
on prescriptions that were not redeemed and using data
covering only those patients who have statutory health in-
surance. Due to the data format, we do not have any
further information about the ongoing of a patient’s dis-
ease, e.g. whether patients who did not use antibiotics suf-
fer from complications afterwards. Information about side
effects of antibiotics is also not available. However, these
important issues will be part of the process evaluation.
Sample size calculation for this study was difficult
because not only the effect size but also the t0 prescribing
rate of antibiotics for the three diagnoses in Germany are
based on estimates. Additionally, as in many trials, we will
also be confronted with the self-selection bias of PCPs.
Those interested or already sensitised for the issues
(antibiotic prescription, communication skills) are more
likely to participate in our study.
However, if our hypothesis is not rejected, the commu-
nication training is an easy and cost-effective way to
reduce antibiotic prescribing for PCPs in Germany, who
are facing symptoms of respiratory infections on a daily
basis and need to make decisions about treatment.
Trial status
The trial has been registered in the German Clinical Trial
Register (DRKS00009566) and is currently recruiting
participants
Endnotes
1It is expected that PCPs can adopt the acquired basics
concerning communication skills to different causes of
consultations. In order to enable a rating of the videos,
no follow-up meetings should be chosen because of lack
of information regarding the prior consultation.
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